期刊
GLYCOBIOLOGY
卷 31, 期 2, 页码 159-165出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/glycob/cwaa057
关键词
drug discovery; LecA; lectin; NMR
资金
- German Research Foundation (DFG) [Ti756/5-1, RA1944/71]
- German Research Foundation
- French National Research Agency [ANR-17-CE11-0048]
The study utilized PrOF NMR to successfully detect ligands binding to LecA, providing a valuable approach for the development of LecA inhibitors in future drug discovery campaigns.
The carbohydrate-binding protein LecA (PA-IL) from Pseudomonas aeruginosa plays an important role in the formation of biofilms in chronic infections. Development of inhibitors to disrupt LecA-mediated biofilms is desired but it is limited to carbohydrate-based ligands. Moreover, discovery of drug-like ligands for LecA is challenging because of its weak affinities. Therefore, we established a protein-observed 19F (PrOF) nuclear magnetic resonance (NMR) to probe ligand binding to LecA. LecA was labeled with 5-fluoroindole to incorporate 5-fluorotryptophanes and the resonances were assigned by site-directed mutagenesis. This incorporation did not disrupt LecA preference for natural ligands, Ca2+ and D-galactose. (D-Gal).Following NMR perturbation of W42, which is located in the carbohydrate-binding region of LecA, allowed to monitor binding of low-affinity ligands such as N-acetyl D-galactosamine (D-GalNAc, K-d = 780 +/- 97 mu M). Moreover, PrOF NMR titration with glycomimetic of LecA p-nitrophenyl beta-D-galactoside (pNPGal, K-d = 54 +/- 6 mu M) demonstrated a 6-fold improved binding of D-Gal proving this approach to be valuable for ligand design in future drug discovery campaigns that aim to generate inhibitors of LecA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据